Dysbiosis in the intensive care unit: Microbiome science coming to the bedside

Journal of Critical Care

Volumn 38, Issue , 2017, Pages 84-91

  Kitsios, Georgios D ^a   Morowitz, Michael J ^a,b   Dickson, Robert P ^c   Huffnagle, Gary B ^c   McVerry, Bryan J ^a   Morris, Alison ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Acute respiratory distress syndrome; Acute respiratory failure; Dysbiosis; Microbiome; Microbiota; Sepsis

Indexed keywords

ANTIBIOTIC AGENT; PREBIOTIC AGENT; PROBIOTIC AGENT;

ACUTE PANCREATITIS; ACUTE RESPIRATORY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC RESISTANCE; ARTIFICIAL VENTILATION; BACTERIUM CULTURE; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIET THERAPY; DRUG EFFICACY; DRUG SAFETY; DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; INTESTINE FLORA; MICROBIAL COMMUNITY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NONHUMAN; REVIEW; SEPSIS; VENTILATOR ASSOCIATED PNEUMONIA; ANIMAL; ANIMAL MODEL; EVIDENCE BASED MEDICINE; INTENSIVE CARE; MICROBIOLOGY; MICROFLORA;

ANIMALS; CRITICAL CARE; CRITICAL ILLNESS; DYSBIOSIS; EVIDENCE-BASED MEDICINE; HUMANS; INTENSIVE CARE UNITS; MICROBIOTA; MODELS, ANIMAL;

EID: 85013775563     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2016.09.029     Document Type: Review

References (85)

1. [1] Sender, R., Fuchs, S., Milo, R., Are We really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 164 (2016), 337–340, 10.1016/j.cell.2016.01.013.
2. [2] Shukla, S.K., Murali, N.S., Brilliant, M.H., Personalized medicine going precise: from genomics to microbiomics. Trends Mol Med 21 (2015), 461–462, 10.1016/j.molmed.2015.06.002.
3. [3] Boyle, A.J., Mac Sweeney, R., McAuley, D.F., Pharmacological treatments in ARDS; a state-of-the-art update. BMC Med, 11, 2013, 166, 10.1186/1741-7015-11-166.
4. [4] Gotts, J.E., Matthay, M.A., Sepsis: pathophysiology and clinical management. BMJ, 353, 2016, i1585, 10.1136/bmj.i1585.
5. [5] Barrett, M.L., Smith, M.W., Elixhauser, A., Honigman, L.S., Pines, J.M., Utilization of intensive care services, 2011. HCUP statistical brief #185, 2014, Agency for Healthcare Research and Quality, Rockville, MD.
6. [6] Morgan, X.C., Huttenhower, C., Chapter 12: human microbiome analysis. PLoS Comput Biol, 8, 2012, e1002808, 10.1371/journal.pcbi.1002808.
7. [7] Cui, L., Morris, A., Huang, L., Beck, J.M., Twigg, H.L., von Mutius, E., et al. The microbiome and the lung. Ann Am Thorac Soc 11:Suppl. 4 (2014), S227–S232, 10.1513/AnnalsATS.201402-052PL.
8. [8] Huang, Y.J., Charlson, E.S., Collman, R.G., Colombini-Hatch, S., Martinez, F.D., Senior, R.M., The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report. Am J Respir Crit Care Med 187 (2013), 1382–1387, 10.1164/rccm.201303-0488WS.
9. [9] Segal, L.N., Rom, W.N., Weiden, M.D., Lung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs. Ann Am Thorac Soc 11 (2014), 108–116, 10.1513/AnnalsATS.201310-339FR.
10. [10] Dickson, R.P., The microbiome and critical illness. Lancet Respir Med 4 (2016), 59–72, 10.1016/S2213-2600(15)00427-0.
11. [11] Marchesi, J.R., Ravel, J., The vocabulary of microbiome research: a proposal. Microbiome, 3, 2015, 31, 10.1186/s40168-015-0094-5.
12. [12] Fernández, J., Tandon, P., Mensa, J., Garcia-Tsao, G., Antibiotic prophylaxis in cirrhosis: good and bad. Hepatology, 2015, 10.1002/hep.28330.
13. [13] Markowicz, P., Wolff, M., Djedaïni, K., Cohen, Y., Chastre, J., Delclaux, C., et al. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. ARDS study group. Am J Respir Crit Care Med 161 (2000), 1942–1948, 10.1164/ajrccm.161.6.9909122.
14. [14] Rynda-Apple, A., Robinson, K.M., Alcorn, J.F., Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease. Infect Immun 83 (2015), 3764–3770, 10.1128/IAI.00298-15.
15. [15] Prescott, H.C., Dickson, R.P., Rogers, M.A., Langa, K.M., Iwashyna, T.J., Hospitalization type and subsequent severe sepsis. Am J Respir Crit Care Med 192 (2015), 581–588, 10.1164/rccm.201503-0483OC.
16. [16] Modi, S.R., Collins, J.J., Relman, D.A., Antibiotics and the gut microbiota. J Clin Invest 124 (2014), 4212–4218, 10.1172/JCI72333.
17. [17] Morowitz, M.J., Carlisle, E.M., Alverdy, J.C., Contributions of intestinal bacteria to nutrition and metabolism in the critically ill. Surg Clin North Am 91 (2011), 771–785, 10.1016/j.suc.2011.05.001 [viii].
18. [18] Brooks, B., Firek, B.A., Miller, C.S., Sharon, I., Thomas, B.C., Baker, R., et al. Microbes in the neonatal intensive care unit resemble those found in the gut of premature infants. Microbiome, 2, 2014, 1, 10.1186/2049-2618-2-1.
19. [19] McKenney, P.T., Pamer, E.G., From hype to hope: the gut microbiota in enteric infectious disease. Cell 163 (2015), 1326–1332, 10.1016/j.cell.2015.11.032.
20. [20] Ferreyra, J.A., Ng, K.M., Sonnenburg, J.L., The enteric two-step: nutritional strategies of bacterial pathogens within the gut. Cell Microbiol 16 (2014), 993–1003, 10.1111/cmi.12300.
21. [21] Yamada, T., Shimizu, K., Ogura, H., Asahara, T., Nomoto, K., Yamakawa, K., et al. Rapid and sustained long-term decrease of fecal short-chain fatty acids in critically ill patients with systemic inflammatory response syndrome. JPEN J Parenter Enteral Nutr 39 (2015), 569–577, 10.1177/0148607114529596.
22. [22] Demehri, F.R., Barrett, M., Ralls, M.W., Miyasaka, E.A., Feng, Y., Teitelbaum, D.H., Intestinal epithelial cell apoptosis and loss of barrier function in the setting of altered microbiota with enteral nutrient deprivation. Front Cell Infect Microbiol, 3, 2013, 105, 10.3389/fcimb.2013.00105.
23. [23] Hand, T.W., The role of the microbiota in shaping infectious immunity. Trends Immunol, 2016.
24. [24] Hill, D.A., Hoffmann, C., Abt, M.C., Du, Y., Kobuley, D., Kirn, T.J., et al. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol 3 (2010), 148–158, 10.1038/mi.2009.132.
25. [25] Bajaj, J.S., The role of microbiota in hepatic encephalopathy. Gut Microbes 5 (2014), 397–403, 10.4161/gmic.28684.
26. [26] Mello, A.M., Paroni, G., Daragjati, J., Pilotto, A., Gastrointestinal microbiota and their contribution to healthy aging. Dig Dis 34 (2016), 194–201, 10.1159/000443350.
27. [27] Esperatti, M., Ferrer, M., Theessen, A., Liapikou, A., Valencia, M., Saucedo, L.M., et al. Nosocomial pneumonia in the intensive care unit acquired by mechanically ventilated versus nonventilated patients. Am J Respir Crit Care Med 182 (2010), 1533–1539, 10.1164/rccm.201001-0094OC.
28. [28] Browne, H.P., Forster, S.C., Anonye, B.O., Kumar, N., Neville, B.A., Stares, M.D., et al. Culturing of “unculturable” human microbiota reveals novel taxa and extensive sporulation. Nature 533 (2016), 543–546, 10.1038/nature17645.
29. [29] Venkataraman, A., Bassis, C.M., Beck, J.M., Young, V.B., Curtis, J.L., Huffnagle, G.B., et al. Application of a neutral community model to assess structuring of the human lung microbiome. MBio, 6, 2015, 10.1128/mBio.02284-14.
30. [30] Dickson, R.P., Erb-Downward, J.R., Prescott, H.C., Martinez, F.J., Curtis, J.L., Lama, V.N., et al. Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid. J Clin Microbiol 52 (2014), 3605–3613, 10.1128/JCM.01028-14.
31. [31] Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A.K., Wertheim, H.F., Sumpradit, N., et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis 13 (2013), 1057–1098, 10.1016/S1473-3099(13)70318-9.
32. [32] Dickson, R.P., Erb-Downward, J.R., Huffnagle, G.B., The role of the bacterial microbiome in lung disease. Expert Rev Respir Med 7 (2013), 245–257, 10.1586/ers.13.24.
33. [33] Judge, K., Harris, S.R., Reuter, S., Parkhill, J., Peacock, S.J., Early insights into the potential of the Oxford Nanopore MinION for the detection of antimicrobial resistance genes. J Antimicrob Chemother 70 (2015), 2775–2778, 10.1093/jac/dkv206.
34. [34] Hiergeist, A., Gläsner, J., Reischl, U., Gessner, A., Analyses of intestinal microbiota: culture versus sequencing. ILAR J 56 (2015), 228–240, 10.1093/ilar/ilv017.
35. [35] Lagier, J.C., Armougom, F., Million, M., Hugon, P., Pagnier, I., Robert, C., et al. Microbial culturomics: paradigm shift in the human gut microbiome study. Clin Microbiol Infect 18 (2012), 1185–1193, 10.1111/1469-0691.12023.
36. [36] Quick, J., Loman, N.J., Duraffour, S., Simpson, J.T., Severi, E., Cowley, L., et al. Real-time, portable genome sequencing for Ebola surveillance. Nature 530 (2016), 228–232, 10.1038/nature16996.
37. [37] Kitsios, G.D., Morris, A., McVerry, B.J., Antibiotic de-escalation: observational causal inference and culture dependence. Intensive Care Med, 2016, 10.1007/s00134-016-4443-z.
38. [38] Price, R., MacLennan, G., Glen, J., SuDDICU collaboration. Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis. BMJ, 348, 2014, g2197, 10.1136/bmj.g2197.
39. [39] Manzanares, W., Lemieux, M., Langlois, P.L., Wischmeyer, P.E., Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit Care, 19, 2015, 262, 10.1186/s13054-016-1434-y.
40. [40] Besselink, M.G., van Santvoort, H.C., Buskens, E., Boermeester, M.A., van Goor, H., Timmerman, H.M., et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371 (2008), 651–659, 10.1016/S0140-6736(08)60207-X.
41. [41] ECOSPOR, Clinical trial. http://www.serestherapeutics.com/clinical-trials/ecospor-trial, 2016 [accessed September 8, 2016].
42. [42] Costeloe, K., Hardy, P., Juszczak, E., Wilks, M., Millar, M.R., Probiotics in preterm infants study collaborative group. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 387 (2016), 649–660, 10.1016/S0140-6736(15)01027-2.
43. [43] Waldor, M.K., Tyson, G., Borenstein, E., Ochman, H., Moeller, A., Finlay, B.B., et al. Where next for microbiome research?. PLoS Biol, 13, 2015, e1002050, 10.1371/journal.pbio.1002050.
44. [44] Ng, K.M., Ferreyra, J.A., Higginbottom, S.K., Lynch, J.B., Kashyap, P.C., Gopinath, S., et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502 (2013), 96–99, 10.1038/nature12503.
45. [45] ARDS Definition Task Force, Ranieri, V.M., Rubenfeld, G.D., Thompson, B.T., Ferguson, N.D., Caldwell, E., et al. Acute respiratory distress syndrome: the berlin definition. JAMA 307 (2012), 2526–2533, 10.1001/jama.2012.5669.
46. [46] Mittal, R., Coopersmith, C.M., Redefining the gut as the motor of critical illness. Trends Mol Med 20 (2014), 214–223, 10.1016/j.molmed.2013.08.004.
47. [47] Deitch, E.A., Gut-origin sepsis: evolution of a concept. Surgeon 10 (2012), 350–356, 10.1016/j.surge.2012.03.003.
48. [48] Morowitz, M.J., Babrowski, T., Carlisle, E.M., Olivas, A., Romanowski, K.S., Seal, J.B., et al. The human microbiome and surgical disease. Ann Surg 253 (2011), 1094–1101, 10.1097/SLA.0b013e31821175d7.
49. [49] Pickard, J.M., Maurice, C.F., Kinnebrew, M.A., Abt, M.C., Schenten, D., Golovkina, T.V., et al. Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. Nature 514 (2014), 638–641, 10.1038/nature13823.
50. [50] Ayres, J.S., Trinidad, N.J., Vance, R.E., Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota. Nat Med 18 (2012), 799–806, 10.1038/nm.2729.
51. [51] Deshmukh, H.S., Liu, Y., Menkiti, O.R., Mei, J., Dai, N., O'Leary, C.E., et al. The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat Med 20 (2014), 524–530, 10.1038/nm.3542.
52. [52] Yu, L.C., Shih, Y.A., Wu, L.L., Lin, Y.D., Kuo, W.T., Peng, W.H., et al. Enteric dysbiosis promotes antibiotic-resistant bacterial infection: systemic dissemination of resistant and commensal bacteria through epithelial transcytosis. Am J Physiol Gastrointest Liver Physiol 307 (2014), G824–G835, 10.1152/ajpgi.00070.2014.
53. [53] Dickson, R.P., Singer, B.H., Newstead, M.H., Falkowski, N.R., Erb-Downward, J.R., Standiford, T.J., et al. Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome. Nat Microbiol, 1, 2016, 16113, 10.1038/nmicrobiol.2016.113.
54. [54] Tsutsumi, R., Horikawa, Y.T., Kume, K., Tanaka, K., Kasai, A., Kadota, T., et al. Whey peptide-based formulas with ω-3 fatty acids are protective in lipopolysaccharide-mediated sepsis. JPEN J Parenter Enteral Nutr 39 (2015), 552–561, 10.1177/0148607114520993.
55. [55] Ghosh, S., DeCoffe, D., Brown, K., Rajendiran, E., Estaki, M., Dai, C., et al. Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis. PLoS One, 8, 2013, e55468, 10.1371/journal.pone.0055468.
56. [56] Myles, I.A., Pincus, N.B., Fontecilla, N.M., Datta, S.K., Effects of parental omega-3 fatty acid intake on offspring microbiome and immunity. PLoS One, 9, 2014, e87181, 10.1371/journal.pone.0087181.
57. [57] Iapichino, G., Callegari, M.L., Marzorati, S., Cigada, M., Corbella, D., Ferrari, S., et al. Impact of antibiotics on the gut microbiota of critically ill patients. J Med Microbiol 57 (2008), 1007–1014, 10.1099/jmm.0.47387-0.
58. [58] Ubeda, C., Taur, Y., Jenq, R.R., Equinda, M.J., Son, T., Samstein, M., et al. Vancomycin-resistant enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 120 (2010), 4332–4341, 10.1172/JCI43918.
59. [59] Taur, Y., Xavier, J.B., Lipuma, L., Ubeda, C., Goldberg, J., Gobourne, A., et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 55 (2012), 905–914, 10.1093/cid/cis580.
60. [60] Earley, Z.M., Akhtar, S., Green, S.J., Naqib, A., Khan, O., Cannon, A.R., et al. Burn injury alters the intestinal microbiome and increases gut permeability and bacterial translocation. PLoS One, 10, 2015, e0129996, 10.1371/journal.pone.0129996.
61. [61] McDonald, D., Ackermann, G., Khailova, L., Baird, C., Heyland, D., Kozar, R., et al. Extreme dysbiosis of the microbiome in critical illness, 1, 2016, 10.1128/mSphere.00199-16.
62. [62] Ojima, M., Motooka, D., Shimizu, K., Gotoh, K., Shintani, A., Yoshiya, K., et al. Metagenomic analysis reveals dynamic changes of whole gut microbiota in the acute phase of intensive care unit patients. Dig Dis Sci 61 (2016), 1628–1634, 10.1007/s10620-015-4011-3.
63. [63] Wang, X., Buhimschi, C.S., Temoin, S., Bhandari, V., Han, Y.W., Buhimschi, I.A., Comparative microbial analysis of paired amniotic fluid and cord blood from pregnancies complicated by preterm birth and early-onset neonatal sepsis. PLoS One, 8, 2013, e56131, 10.1371/journal.pone.0056131.
64. [64] Stewart, C.J., Marrs, E.C., Magorrian, S., Nelson, A., Lanyon, C., Perry, J.D., et al. The preterm gut microbiota: changes associated with necrotizing enterocolitis and infection. Acta Paediatr 101 (2012), 1121–1127, 10.1111/j.1651-2227.2012.02801.x.
65. [65] Shaw, A.G., Sim, K., Randell, P., Cox, M.J., McClure, Z.E., Li, M.S., et al. Late-onset bloodstream infection and perturbed maturation of the gastrointestinal microbiota in premature infants. PLoS One, 10, 2015, e0132923, 10.1371/journal.pone.0132923.
66. [66] Drell, T., Lutsar, I., Stšepetova, J., Parm, U., Metsvaht, T., Ilmoja, M.L., et al. The development of gut microbiota in critically ill extremely low birth weight infants assessed with 16S rRNA gene based sequencing. Gut Microbes 5 (2014), 304–312, 10.4161/gmic.28849.
67. [67] Greenwood, C., Morrow, A.L., Lagomarcino, A.J., Altaye, M., Taft, D.H., Yu, Z., et al. Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter. J Pediatr 165 (2014), 23–29, 10.1016/j.jpeds.2014.01.010.
68. [68] Madan, J.C., Salari, R.C., Saxena, D., Davidson, L., O'Toole, G.A., Moore, J.H., et al. Gut microbial colonisation in premature neonates predicts neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 97 (2012), F456–F462, 10.1136/fetalneonatal-2011-301373.
69. [69] Mai, V., Torrazza, R.M., Ukhanova, M., Wang, X., Sun, Y., Li, N., et al. Distortions in development of intestinal microbiota associated with late onset sepsis in preterm infants. PLoS One, 8, 2013, e52876, 10.1371/journal.pone.0052876.
70. [70] Mshvildadze, M., Neu, J., Shuster, J., Theriaque, D., Li, N., Mai, V., Intestinal microbial ecology in premature infants assessed with non-culture-based techniques. J Pediatr 156 (2010), 20–25, 10.1016/j.jpeds.2009.06.063.
71. [71] Stewart, C.J., Nelson, A., Scribbins, D., Marrs, E.C., Lanyon, C., Perry, J.D., et al. Bacterial and fungal viability in the preterm gut: NEC and sepsis. Arch Dis Child Fetal Neonatal Ed 98 (2013), F298–F303, 10.1136/archdischild-2012-302119.
72. [72] Stewart, C.J., Marrs, E.C., Nelson, A., Lanyon, C., Perry, J.D., Embleton, N.D., et al. Development of the preterm gut microbiome in twins at risk of necrotising enterocolitis and sepsis. PLoS One, 8, 2013, e73465, 10.1371/journal.pone.0073465.
73. [73] Sim, K., Shaw, A.G., Randell, P., Cox, M.J., McClure, Z.E., Li, M.S., et al. Dysbiosis anticipating necrotizing enterocolitis in very premature infants. Clin Infect Dis 60 (2015), 389–397, 10.1093/cid/ciu822.
74. [74] Dickson, R.P., Erb-Downward, J.R., Huffnagle, G.B., Homeostasis and its disruption in the lung microbiome. Am J Physiol Lung Cell Mol Physiol 309 (2015), L1047–L1055, 10.1152/ajplung.00279.2015.
75. [75] Poroyko, V., Meng, F., Meliton, A., Afonyushkin, T., Ulanov, A., Semenyuk, E., et al. Alterations of lung microbiota in a mouse model of LPS-induced lung injury. Am J Physiol Lung Cell Mol Physiol 309 (2015), L76–L83, 10.1152/ajplung.00061.2014.
76. [76] Kelly, B.J., Imai, I., Bittinger, K., Laughlin, A., Fuchs, B.D., Bushman, F.D., et al. Composition and dynamics of the respiratory tract microbiome in intubated patients. Microbiome, 4, 2016, 7, 10.1186/s40168-016-0151-8.
77. [77] Huebinger, R.M., Liu, M.M., Dowd, S.E., Rivera-Chavez, F.A., Boynton, J., Carey, C., et al. Examination with next-generation sequencing technology of the bacterial microbiota in bronchoalveolar lavage samples after traumatic injury. Surg Infect (Larchmt) 14 (2013), 275–282, 10.1089/sur.2012.095.
78. [78] Bahrani-Mougeot, F.K., Paster, B.J., Coleman, S., Barbuto, S., Brennan, M.T., Noll, J., et al. Molecular analysis of oral and respiratory bacterial species associated with ventilator-associated pneumonia. J Clin Microbiol 45 (2007), 1588–1593, 10.1128/JCM.01963-06.
79. [79] Bousbia, S., Papazian, L., Saux, P., Forel, J.M., Auffray, J.P., Martin, C., et al. Repertoire of intensive care unit pneumonia microbiota. PLoS One, 7, 2012, e32486, 10.1371/journal.pone.0032486.
80. [80] Lu, W., Yu, J., Ai, Q., Liu, D., Song, C., Li, L., Increased constituent ratios of Klebsiella sp., Acinetobacter sp., and streptococcus sp. and a decrease in microflora diversity may be indicators of ventilator-associated pneumonia: a prospective study in the respiratory tracts of neonates. PLoS One, 9, 2014, e87504, 10.1371/journal.pone.0087504.
81. [81] Ravel, J., Wommack, K.E., All hail reproducibility in microbiome research. Microbiome, 2, 2014, 8, 10.1186/2049-2618-2-8.
82. [82] NCI-NHGRI Working Group on Replication in Association Studies, Chanock, S.J., Manolio, T., Boehnke, M., Boerwinkle, E., Hunter, D.J., et al. Replicating genotype–phenotype associations. Nature 447 (2007), 655–660, 10.1038/447655a.
83. [83] Alivisatos, A.P., Blaser, M.J., Brodie, E.L., Chun, M., Dangl, J.L., Donohue, T.J., et al. MICROBIOME. A unified initiative to harness Earth's microbiomes. Science 350 (2015), 507–508, 10.1126/science.aac8480.
84. [84] Dubilier, N., McFall-Ngai, M., Zhao, L., Microbiology: create a global microbiome effort. Nature 526 (2015), 631–634, 10.1038/526631a.
85. [85] Knight, R., Why microbiome treatments could pay off soon. Nature, 518, 2015, S5, 10.1038/518S5a.